Evidence map›Paper›PMID 39085520›Full record

ReviewDer Nervenarzt2024

[Kratom-From natural remedy to addictive drug and back].

Christian P Müller, Yuting Yang, Darshan Singh, Bernd Lenz, Elisabeth Müller

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Nervenarzt, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christian P MüllerBereich Suchtmedizin, Klinik für Psychiatrie und Psychosomatik, Universitätsklinikum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Deutschland. christian.mueller@uk-erlangen.de.ORCID http://orcid.org/0000-0002-5325-9900
Yuting YangCentre for Drug Research, Universiti Sains Malaysia, Penang, Malaysia.
Darshan SinghCentre for Drug Research, Universiti Sains Malaysia, Penang, Malaysia.
Bernd LenzDepartment für Süchtiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Ruprecht-Karls-Universität Heidelberg, Mannheim, Deutschland.
Elisabeth MüllerDepartment für Psychiatrie und Psychotherapie, Paracelsus Medizinische Privatuniversität, Nürnberg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKratom/ketum is a psychoactive herbal preparation that has been used for a long time as a remedy and performance-enhancing substance in Southeast Asia. The advancement of globalization is making kratom increasingly more available in the western world, where it is becoming increasingly more used.

objectiveThe current research on kratom and its ingredients is presented. MATERIAL AND

methodsAn overview of the use and effects of kratom is exemplary given on the basis of reports. The instrumentalization of the drug and its consequences up to the development of addiction are discussed.

resultsConsumption is accompanied by several instrumentalizeable effects so that kratom is used as a therapeutic substance in the self-management of pain, anxiety and depression as well as other substance addictions. Another benefit comes from the performance-enhancing effects on physical work and in a social context. Consumption is usually well controlled, rarely escalates and has few and mostly mild aversive side effects. The danger arises from consumption particularly when there is an escalation of the dose and from mixed consumption with other psychoactive substances. The main alkaloid mitragynine and the more potent 7‑hydroxy-mitragynine are considered mainly responsible for the effect. Both have a complex pharmacology that involves partial µ‑opioid receptor agonism. DISCUSSION: Epidemiological, clinical and neurochemical studies have shown that kratom only has a limited addictive drug profile, which might suggest a medical use as a remedy or substitute in addiction treatment.

Indexed as

MitragynaSubstance-Related DisordersHumansPhytotherapyPlant ExtractsSecologanin Tryptamine AlkaloidsPlant ExtractsSecologanin Tryptamine AlkaloidsAddictionEnhanced performanceInstrumentalizationKetumMitragynine

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.